Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects
Public ClinicalTrials.gov record NCT00043966. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open-Label Study of 800 Mg Lopinavir/200 Mg Ritonavir QD in Combination With Tenofovir and Emtricitabine Vs. 400 Mg Lopinavir /100 Mg Ritonavir BID in Combination With Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the safety, tolerability and antiviral activity between once-daily (QD) and twice-daily (BID) dosing of lopinavir/ritonavir and to further characterize the pharmacokinetics of once-daily dosing of lopinavir/ritonavir.
Study identification
- NCT ID
- NCT00043966
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 200 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2002 (Type not available)
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jul 27, 2006
Started 2002
United States locations
- U.S. sites
- 29
- U.S. states
- 15
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Phoenix Body Positive | Phoenix | Arizona | 85006 | — |
| Pacific Oaks Research | Beverly Hills | California | 90211 | — |
| Orange County Center for Special Immunology | Fountain Valley | California | 92708 | — |
| Living Hope Clinical Foundation | Long Beach | California | 90813 | — |
| AIDS Healthcare Foundation Research Center | Los Angeles | California | 90027 | — |
| IDS Research Initiative | Altamonte Springs | Florida | 32701 | — |
| South Florida Clinical Research | Atlantis | Florida | 33462 | — |
| Comprehensive Care Center | Fort Lauderdale | Florida | 33311 | — |
| Gary J. Richmond, MD | Fort Lauderdale | Florida | 33316 | — |
| Associates in Research | Fort Myers | Florida | 33901 | — |
| Morris, Sklaver, Mestre & Denney, M.D., PA | Plantation | Florida | 33317 | — |
| Health Positive | Safety Harbor | Florida | 34695 | — |
| Infectious Disease Research Institute, Inc. | Tampa | Florida | 33614 | — |
| Treasure Coast Infectious Disease Consultants | Vero Beach | Florida | 32960 | — |
| AIDS Research Consortium of Atlanta Inc. | Atlanta | Georgia | 30308 | — |
| Donna E. Sweet, MD | Wichita | Kansas | 67214 | — |
| Drs. Combs and Lutz | New Orleans | Louisiana | 70115 | — |
| St. Michael's Medical Center | Newark | New Jersey | 07102-9880 | — |
| Polari Medical Group | New York | New York | 10011 | — |
| Wake Forest University School of Medicine | Winston-Salem | North Carolina | 27157-1042 | — |
| Akron Infectious Disease, Inc. | Akron | Ohio | 44304 | — |
| Associates in Medical and Mental Health, P.C. | Tulsa | Oklahoma | 74114 | — |
| The Research & Education Group | Portland | Oregon | 97209-2535 | — |
| Philadelphia FIGHT | Philadelphia | Pennsylvania | 19107 | — |
| Triangle Medical | Philadelphia | Pennsylvania | 19107 | — |
| Central Texas Clinical Research | Austin | Texas | 78705 | — |
| Joseph C. Gathe, Jr, MD | Houston | Texas | 77004 | — |
| Southampton Medical Group | Houston | Texas | 77098 | — |
| Hampton Roads Medical Specialists | Hampton | Virginia | 23666 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00043966, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 27, 2006 · Synced Nov 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00043966 live on ClinicalTrials.gov.